Bevacizumab Combined with Chemotherapy Improves Survival for Patients with Metastatic Colorectal Cancer: Evidence from Meta Analysis.

PLoS One · 2016 · PMC5006969 · PMID 27579775

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Statistically significant benefit in overall survival was present in fluorouracil monotherapy (HR = 0.71; 95% CI: 0.61–0.83; p <0.0001) and oxaliplatin based chemotherapy regimens (HR = 0.83; 95% CI: 0.74–0.93; p = 0.001), while the results for irinotecan based and capecitabine regimens did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.